ADHD in the News 2024-09-05
US allows increased production of Takeda’s ADHD drug to address shortage
Sept 4 (Reuters) - The U.S. Drug Enforcement Administration (DEA) has increased the production limit for Takeda Pharmaceutical's (4502.T), opens new tab ADHD drug Vyvanse and its generic versions by about 24% to address the medicine's ongoing shortage in the United States. The raised production limit follows the Food and Drug Administration's request in July, the DEA said in a notice on Tuesday.
Study reveals slight increase in ADHD risk from prenatal cannabis exposure
A new study reveals nuanced findings on the neuropsychiatric risks of prenatal cannabis exposure. The research found a slight increase in the risk of ADHD and a heightened vulnerability to cannabis use in offspring. These results highlight the need for continued caution and further investigation into the long-term effects of cannabis use during pregnancy.
Rising number of women diagnosed with ADHD as adults
ABC News’ Diane Macedo discusses why there is a rising number of women being diagnosed with ADHD later in life.
Adolescents with smaller amygdala region of the brain have higher risk of developing ADHD
A study conducted in Hungary found that adolescents with a smaller volume in the amygdala region of the brain have a higher risk of attention-deficit/hyperactivity disorder (ADHD). They also tend to experience more severe symptoms of this disorder. The research was published in Research on Child and Adolescent Psychopathology.
Higher ADHD diagnosis and prescriptions for children born in July and August, research finds
Children born in July and August are at least 40% more likely to be diagnosed with—and to receive prescriptions for—attention deficit hyperactivity disorder (ADHD), than children born in September and October, new research has found. This research is being presented at the European Association of Labour Economics on September 7 and is published as a discussion paper by the IZA Institute of Labour Economics.
Navigating ADHD Treatment Amid the Rise of Social Media and Self-Diagnosis
Join Tim Wilens, MD, co-director of the Center for Addiction Medicine at Massachusetts General Hospital and a professor of psychiatry at Harvard Medical School, as he discusses innovative, multidisciplinary approaches for managing ADHD beyond traditional medications.
Study links melatonin secretion to ADHD symptoms in children
A study conducted by researchers from Hamamatsu University School of Medicine, in collaboration with several international institutions, has unveiled a critical link between melatonin secretion and the severity of ADHD (attention deficit hyperactivity disorder) symptoms in children. The findings, published in Psychiatry Research Communications, suggest that genetic variations affecting melatonin production may play a significant role in the development and exacerbation of ADHD symptoms.
Diagnosed as an Adult
"After being so low for so long, I’m just happy to be alive.”
An Artist’s Guide to ADHD and Getting Stuff Done
Illustrator and podcaster Andy J. Pizza shares the routines and practices that help to direct his creativity.
How Much Does Special Education Truly Cost? Finally, an Answer Is on the Horizon
How much do America’s schools spend to provide special education services to students with disabilities? How have special education costs nationwide risen over the last two decades? What is the typical cost of providing services to a K-12 student who has autism, or ADHD, or Down syndrome? The answer to all of these questions is painfully simple: We don’t know.
Revolutionizing education through school-based healthcare
The collaborative nature of SBHCs allows clinicians to dive into each student's specific needs, creating a personalized curriculum extending beyond medical checkups
Caught Between Tears and Stoicism
Key points: Society criticizes disabled people for showing both too much or too little emotion. Gus Walz's emotional display highlights bias against authentic expression in disability. Emotional expression should be seen as a human experience, not defined by disability.